iCoreConnect Inc. specializes in cloud-based software solutions for the healthcare industry, focusing on enhancing operational efficiencies and compliance for medical practices. The company's unique competitive advantage lies in its proprietary technology that integrates electronic health records (EHR) with telehealth services, primarily targeting small to mid-sized healthcare providers in the U.S.
TechnologySoftware - Applicationhigh - The company has significant fixed costs associated with software development and infrastructure, allowing for high operating leverage as revenue scales.
Business Overview
01Subscription fees for software services (estimated 70%)
02Consulting and implementation services (estimated 20%)
03Training and support services (estimated 10%)
iCoreConnect generates revenue primarily through subscription-based models for its software solutions, which provide recurring income. The company benefits from high gross margins of 76.8%, indicating strong pricing power due to the specialized nature of its offerings. Its competitive advantage is reinforced by a robust customer retention rate, driven by the critical nature of compliance and operational efficiency in healthcare.
What Moves the Stock
Adoption rates of telehealth services among healthcare providers
High operating losses impacting financial stability
StructuralCompetitiveBalance Sheet
Macro Sensitivity
Economic Cycle
moderate - The healthcare sector is generally resilient during economic downturns, but discretionary spending on technology may decline.
Interest Rates
Higher interest rates could increase the cost of capital for iCoreConnect, impacting its ability to invest in growth initiatives and potentially reducing demand for its services as healthcare providers face tighter budgets.
Credit
minimal - The company has a negative debt/equity ratio, indicating low reliance on debt financing.
Live Conditions
S&P 500 FuturesNasdaq 100 Futures
Profile
growth - Investors seeking high-growth potential in the healthcare technology sector.
high - The stock has exhibited significant volatility, with a 450% return over the last three months followed by a 63.3% decline over six months.